Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 21, 2022
July 31, 2025
791aaeaa-9e86-4bc4-8b71-477a833920f1
Related Documents
Topical Dermatologic Corticosteroids: In Vivo Bioequivalence
Guidance DocumentOctober 24, 2023Center for Drug Evaluation and Research
In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
In Vitro Permeation Test Studies for Topical Drug Products Submitted in ANDAs
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox